Dextrose (dextrose monohydrate) NDC 17271-721

NDC codes

FDA NDC Directory

Product NDC (as listed)17271-721Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17271-0721Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
17271-721-05	17271072105	30 BAG in 1 CASE (17271-721-05) / 250 mL in 1 BAGMarketed from Feb 5, 2020
17271-721-06	17271072106	20 BAG in 1 CASE (17271-721-06) / 500 mL in 1 BAGMarketed from Feb 5, 2020
17271-721-07	17271072107	10 BAG in 1 CASE (17271-721-07) / 1000 mL in 1 BAGMarketed from Feb 5, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dextrose
Generic name (nonproprietary): dextrose monohydrate
Active ingredients: Dextrose monohydrate — 100 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Becton Dickinson and Company
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209448
Marketing start: Feb 5, 2020
Listing expires: Dec 31, 2027
Identifiers: Product ID 17271-721_16de339e-70a9-4375-8e4b-31b6313b6666SPL ID 16de339e-70a9-4375-8e4b-31b6313b6666SPL set ID 8e7046f8-841e-465a-af69-af9fb3d6799dRxCUI 1795477, 1795480, 1795481UNII LX22YL083G

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N417271072105 followed by a unit qualifier and the quantity

Package 17271-0721-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2026.

Indications (excerpt from the label)

Dextrose Injection is indicated as source of water and calories. Dextrose Injection is indicated as a source of water and calories. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209448

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209448
Product	Strength	Form · route	Labeler	Product NDC
Dextrosedextrose monohydrate	Dextrose monohydrate 100 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-824
Dextrose	Dextrose monohydrate 100 mg/mL	Injection, SolutionIntravenous	HF Acquisition Co. LLC. DBA HealthFirst	51662-1680